Melinta Therapeutics’ $1 Billion Acquistion of Infectious Disease Business from The Medicines Company

Ambrogio Visconti
Tagged:

Willkie and Cadwalader, Wickersham & Taft LLP advised on the deal Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now